Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

The programmed cell death 1/programmed cell death 1 ligand 1 pathway was successfully targeted in cancer immunotherapy. Elevated interleukin‐17 (IL‐17), which is known in autoimmune diseases, has recently been recognized in cancer patients. We investigated the role of IL‐17 in the regulation of expr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Aotsuka, Aeri, Matsumoto, Yoko, Arimoto, Takahide, Kawata, Akira, Ogishima, Juri, Taguchi, Ayumi, Tanikawa, Michihiro, Sone, Kenbun, Mori‐Uchino, Mayuyo, Tsuruga, Tetsushi, Oda, Katsutoshi, Kawana, Kei, Osuga, Yutaka, Fujii, Tomoyuki
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778630/
https://ncbi.nlm.nih.gov/pubmed/31432577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14174
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares